On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics
The New York Times
Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.
Insulin for $35 a month. A limit of $2,000 a year in out-of-pocket drug costs for older Americans. Billions of dollars in savings for Medicare resulting from drug negotiations.
Whether these policies expand or, in the case of the negotiations, survive at all may be determined by the election in November.
Vice President Kamala Harris, the Democratic nominee, has vowed to extend President Biden’s policies to more drugs and more Americans. She plans to use savings from expanding negotiations to help pay for a sweeping new proposal that would cover long-term care at home for people on Medicare.
Former President Donald J. Trump, the Republican nominee, is a wild card. He has offered few specifics about what he would do on drug pricing.
Last week, he reversed his position on a policy he had proposed in his first term that rattled pharmaceutical companies: tying drug prices to what other wealthy countries pay. In a second term, he would face pressure from some Republicans to undo Mr. Biden’s Medicare negotiation program — although he once promoted the same thing.
Drug pricing has not featured prominently in a presidential campaign that has been dominated by immigration, abortion and the economy. Mr. Trump, in particular, rarely talks about the issue. Nor is it top of mind for many voters.
New findings suggest that an extraordinarily powerful and dangerous burst of radiation might flare from our sun in the future.
Anchored by juicy braised duck and finished with an unforgettable family-size crème brûlée, this menu from Clare de Boer will have everyone talking.
The shower forms from the debris of an asteroid and peaks this weekend. But a nearly full moon could interfere with viewing.
The opposing paths taken by two powerful firms — Benchmark and Andreessen Horowitz — embody a profound debate about the future of an industry that funds and fosters American innovation.
Aaron Siri, who specializes in vaccine lawsuits, has been at Robert F. Kennedy Jr.’s side reviewing candidates for top jobs at the Department of Health and Human Services.
Scientists are concerned that the H5N1 virus could set off another human pandemic. But it is already putting species under pressure in the wild.
The scarcity and fragility of rare old bottles makes them naturally memorable, but these 12 younger wines had their own unforgettable charms.
DNA from European fossils dating back 45,000 years offers new clues to how our species spread across the world.
An intense struggle has unfolded in Washington between companies and officials over where to draw the line on selling technology to China.
There’s a universal — and easy — answer to a common kitchen predicament.
More adolescents than ever are watching it. What’s needed, researchers say, are frank conversations and “porn literacy.”